Jorge Rico-Fontalvo

11PUBLICATIONS
102CO-AUTHORS
Major global burdens of diseaseNutrigenomics and personalised nutritionCancer geneticsCardiology (incl. cardiovascular diseases)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 28, 2026
Efficacy and Safety of Finerenone in Patients Aged 65 Years or Older with Diabetic Kidney Disease: Subgroup Analysis of the FINDKDLATAM Study.

|Mar 18, 2026
Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.

Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Alicia Elbert

|Jul 29, 2025
Obesity-Related Kidney Disease: A Growing Threat to Renal Health.

Juan León-Román, Marina López-Martínez, Alexandra Esteves

|Jun 02, 2025
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1.

Andres Rosende, Cesar Romero, Donald J DiPette

|Dec 16, 2024
Author's Reply to Peronard and Mayntz: "SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect".

David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez

|Nov 08, 2024
Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective.

Jorge Rico-Fontalvo, Maricely Reina, María José Soler

Pageof 2

Frequent Collaborators

3 joint publications

Rodrigo Daza-Arnedo

3 joint publications

María Cristina Martínez-Ávila

3 joint publications

Thyago Proença de Moraes

3 joint publications

Jose Cabrales